Search Results - "LUTCHMAN, M"

Refine Results
  1. 1
  2. 2

    Reassignment of the EPB4.1 gene to 1p36 and assessment of its involvement in neuroblastomas by Huang, S, Lichtenauer, U D, Pack, S, Wang, C, Kim, A C, Lutchman, M, Koch, C A, Torres-Cruz, J, Huang, S C, Benz, Jr, E J, Christiansen, H, Dockhorn-Dworniczak, B, Poremba, C, Vortmeyer, A O, Chishti, A H, Zhuang, Z

    Published in European journal of clinical investigation (01-10-2001)
    “…EPB4.1 has been previously mapped to human chromosome 1p33-p34.2. In contradiction to this chromosomal location, we have mapped EPB4.1-1p36 by using…”
    Get full text
    Journal Article
  3. 3

    Neurofibromatosis type 2: a new mechanism of tumor suppression by Lutchman, Mohini, Rouleau, Guy A.

    “…Neurofibromatosis type 2 (NF2) is an autosomal dominant disease which predisposes primarily to CNS tumors such as schwannomas (vestibular and spinal),…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Reassignment of the EPB4·1 gene to 1p36 and assessment of its involvement in neuroblastomas by Huang, S., Lichtenauer, U. D., Pack, S., Wang, C., Kim, A. C., Lutchman, M., Koch, C. A., Torres-Cruz, J., Huang, S.-C., Benz Jr, E. J., Christiansen, H., Dockhorn-Dworniczak, B., Poremba, C., Vortmeyer, A. O., Chishti, A. H., Zhuang, Z.

    Published in European journal of clinical investigation (01-10-2001)
    “…Objectives EPB4·1 has been previously mapped to human chromosome 1p33‐p34.2. In contradiction to this chromosomal location, we have mapped EPB4·1–1p36 by using…”
    Get full text
    Journal Article
  6. 6

    Schwannomin: new insights into this member of the band 4.1 superfamily by Belliveau, M J, Lutchman, M, Claudio, J O, Marineau, C, Rouleau, G A

    Published in Biochemistry and cell biology (01-09-1995)
    “…Neurofibromatosis type 2 (NF2) is an autosomal dominant disease characterized by the development of central nervous system tumours. The NF2 gene was recently…”
    Get more information
    Journal Article
  7. 7

    HMG-CoA reductase inhibitors promote cholesterol-dependent Akt/PKB translocation to membrane domains in endothelial cells by SKALETZ-ROROWSKI, Adriane, LUTCHMAN, Mohini, KUREISHI, Yasuko, LEFER, David J, FAUST, Jerry R, WALSH, Kenneth

    Published in Cardiovascular research (2003)
    “…Recent results have shown that 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors referred to as statins rapidly activate the protein kinase…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Neurofibromatosis 2 tumor suppressor protein colocalizes with ezrin and CD44 and associates with actin-containing cytoskeleton by Sainio, M, Zhao, F, Heiska, L, Turunen, O, den Bakker, M, Zwarthoff, E, Lutchman, M, Rouleau, G A, Jääskeläinen, J, Vaheri, A, Carpén, O

    Published in Journal of cell science (01-09-1997)
    “…Neurofibromatosis 2 (NF2) protein (merlin; schwannomin) is a tumor suppressor involved in tumorigenesis of NF2-associated and sporadic schwannomas and…”
    Get full text
    Journal Article
  10. 10

    Complete deficiency of glycophorin A in red blood cells from mice with targeted inactivation of the band 3 (AE1) gene by HASSOUN, Y. H, HANADA, T, LUTCHMAN, M, SAHR, K. E, PALEK, J, HANSPAL, M, CHISHTI, A. H

    Published in Blood (15-03-1998)
    “…Glycophorin A is the major transmembrane sialoglycoprotein of red blood cells. It has been shown to contribute to the expression of the MN and Wright blood…”
    Get full text
    Journal Article
  11. 11

    The neurofibromatosis type 2 gene product, Schwannomin, suppresses growth of NIH 3T3 cells by LUTCHMAN, N, ROULEAU, G. A

    Published in Cancer research (Chicago, Ill.) (01-06-1995)
    “…Cancer is a multistep process that involves the activation of oncogenes and the inactivation of antioncogenes. Recently, a new putative tumor suppressor, the…”
    Get full text
    Journal Article
  12. 12

    Complete Deficiency of Glycophorin A in Red Blood Cells From Mice With Targeted Inactivation of the Band 3 (AE1) Gene by Hassoun, Hani, Hanada, Toshihiko, Lutchman, Mohini, Sahr, Kenneth E., Palek, Jiri, Hanspal, Manjit, Chishti, Athar H.

    Published in Blood (15-03-1998)
    “…Glycophorin A is the major transmembrane sialoglycoprotein of red blood cells. It has been shown to contribute to the expression of the MN and Wright blood…”
    Get full text
    Journal Article
  13. 13

    Neurofibromatosis type 2: A new mechanism of tumor suppression by Lutchman, M, Rouleau, G A

    Published in Trends in neurosciences (Regular ed.) (01-01-1996)
    “…Neurofibromatosis type 2 (NF2) is an autosomal dominant disease which predisposes primarily to CNS tumors such as schwannomas (vestibular and spinal),…”
    Get full text
    Journal Article
  14. 14

    Targeted Inactivation of Murine Band 3 (AE1) Gene Produces a Hypercoagulable State Causing Widespread Thrombosis In Vivo by Hassoun, Hani, Wang, Ying, Vassiliadis, John, Lutchman, Mohini, Palek, Jiri, Aish, Leo, Aish, Irene S., Liu, Shih-Chun, Chishti, Athar H.

    Published in Blood (01-09-1998)
    “…Only 5% to 10% of band 3 null mice survive the neonatal period. To determine the cause of death, 3 adult and 11 newborn band 3 null mice were submitted for…”
    Get full text
    Journal Article
  15. 15

    Fontan Liver Lesions: Not Always HCC by Haeffele, Christiane, Aggarwal, Avin, Lutchman, Glen, Veldtman, Gruschen R., Wu, Fred M., Lui, George K.

    Published in JACC. Case reports (01-08-2019)
    “…A 24-year-old Fontan procedure patient underwent surveillance liver cardiac magnetic resonance imaging. Findings were suggestive of hepatocellular… A…”
    Get full text
    Journal Article
  16. 16

    Widespread but cell type-specific expression of the mouse neurofibromatosis type 2 gene by Claudio, J O, Lutchman, M, Rouleau, G A

    Published in Neuroreport (02-10-1995)
    “…Neurofibromatosis type 2 (NF2) is an autosomal dominant disease in which loss of function mutations of the NF2 gene lead to the development of schwannomas,…”
    Get more information
    Journal Article
  17. 17

    Germline deletion in a neurofibromatosis type 2 kindred inactivates the NF2 gene and a candidate meningioma locus by Sanson, M, Marineau, C, Desmaze, C, Lutchman, M, Ruttledge, M, Baron, C, Narod, S, Delattre, O, Lenoir, G, Thomas, G

    Published in Human molecular genetics (01-08-1993)
    “…Neurofibromatosis type 2 (NF2) is an autosomal dominant disease which predisposes to the development of schwannomas, meningiomas, ependymomas, and juvenile…”
    Get more information
    Journal Article
  18. 18
  19. 19

    cDNA sequence, genomic structure, and expression of the mouse dematin gene (Epb4.9) by Azim, A C, Kim, A C, Lutchman, M, Andrabi, S, Peters, L L, Chishti, A H

    Published in Mammalian genome (01-10-1999)
    “…Dematin (protein 4.9 region) is an actin-bundling phosphoprotein of the erythroid membrane cytoskeleton (Rana et al. 1993; Azim et al. 1995). Although much is…”
    Get full text
    Journal Article
  20. 20

    Targeted inactivation of murine band 3 (AE1) gene produces a hypercoagulable state causing widespread thrombosis in vivo by HASSOUN, H, YING WANG, VASSILIADIS, J, LUTCHMAN, M, PALEK, J, AISH, L, AISH, I. S, LIU, S.-C, CHISHTI, A. H

    Published in Blood (01-09-1998)
    “…Only 5% to 10% of band 3 null mice survive the neonatal period. To determine the cause of death, 3 adult and 11 newborn band 3 null mice were submitted for…”
    Get full text
    Journal Article